Bioceltix Balance Sheet Health
Financial Health criteria checks 6/6
Bioceltix has a total shareholder equity of PLN44.9M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN52.0M and PLN7.1M respectively.
Key information
0%
Debt to equity ratio
zł0
Debt
Interest coverage ratio | n/a |
Cash | zł20.04m |
Equity | zł44.89m |
Total liabilities | zł7.12m |
Total assets | zł52.01m |
Financial Position Analysis
Short Term Liabilities: BCX's short term assets (PLN50.3M) exceed its short term liabilities (PLN7.0M).
Long Term Liabilities: BCX's short term assets (PLN50.3M) exceed its long term liabilities (PLN139.9K).
Debt to Equity History and Analysis
Debt Level: BCX is debt free.
Reducing Debt: BCX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BCX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BCX has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 47.5% each year.